Experienced in Immune Thrombocytopenic Purpura (ITP)

Monika Danecka-Dlugosz

Maria Sklodowska Curie National Research Institute Of Oncology Krakow Branch
Krakow, MA, PL 
Experienced in Immune Thrombocytopenic Purpura (ITP)
Maria Sklodowska Curie National Research Institute Of Oncology Krakow Branch
Krakow, MA, PL 
OverviewLocationsClinical Research

Overview

Monika Danecka-Dlugosz practices in Krakow, Poland. Ms. Danecka-Dlugosz is rated as an Experienced expert by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Mantle Cell Lymphoma (MCL), and Bone Marrow Transplant.

Her clinical research consists of co-authoring 47 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Immune Thrombocytopenic Purpura (ITP).

Gender
Female

Locations

Maria Sklodowska Curie National Research Institute of Oncology Krakow Branch
Krakow, MA, Poland
Other Locations
Mikołaja Kopernika 17 Str, Krakow, MA 30501, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 1, First-in-Human, Open-Label, Dose Escalation Study of MGD013, A Bispecific DART® Protein Binding PD-1 and LAG-3 in Patients With Unresectable or Metastatic Neoplasms
A Phase 1, First-in-Human, Open-Label, Dose Escalation Study of MGD013, A Bispecific DART® Protein Binding PD-1 and LAG-3 in Patients With Unresectable or Metastatic Neoplasms
Enrollment Status: Completed
Publish Date: December 21, 2023
Intervention Type: Biological
Study Drugs: MGD013, MGD013+Margetuximab
Study Phase: Phase 1

47 Total Publications

Higher Mortality in Patients With Diffuse Large B-cell Lymphoma Pre-Existing Arterial Hypertension-Real World Data of the Polish Lymphoma Research Group.
Higher Mortality in Patients With Diffuse Large B-cell Lymphoma Pre-Existing Arterial Hypertension-Real World Data of the Polish Lymphoma Research Group.
Journal: Heart, lung & circulation
Published: December 06, 2023

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Danecka-Dlugosz's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile